You can:
Name | Kappa-type opioid receptor |
---|---|
Species | Homo sapiens (Human) |
Gene | OPRK1 |
Synonym | K-OR-1 KOPr OP2 KOP KOR-1 [ Show all ] |
Disease | Obesity Opiate dependence Inflammatory bowel disease Erythema Diarrhea-predominant IBS [ Show all ] |
Length | 380 |
Amino acid sequence | MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV |
UniProt | P41145 |
Protein Data Bank | 6b73, 4djh |
GPCR-HGmod model | P41145 |
3D structure model | This structure is from PDB ID 6b73. |
BioLiP | BL0402244,BL0402246, BL0224693,BL0224694, BL0402243,BL0402245 |
Therapeutic Target Database | T60693 |
ChEMBL | CHEMBL237 |
IUPHAR | 318 |
DrugBank | BE0000632 |
Name | U-69593 |
---|---|
Molecular formula | C22H32N2O2 |
IUPAC name | N-methyl-2-phenyl-N-[(5R,7S,8S)-7-pyrrolidin-1-yl-1-oxaspiro[4.5]decan-8-yl]acetamide |
Molecular weight | 356.51 |
Hydrogen bond acceptor | 3 |
Hydrogen bond donor | 0 |
XlogP | 3.0 |
Synonyms | D01FSE J5S4K6TKTG N-methyl-2-phenyl-N-[(5R,8S,9S)-9-pyrrolidin-1-yl-4-oxaspiro[4.5]decan-8-yl]acetamide PGZRDDYTKFZSFR-ONTIZHBOSA-N U-69593, solid [ Show all ] |
Inchi Key | PGZRDDYTKFZSFR-ONTIZHBOSA-N |
Inchi ID | InChI=1S/C22H32N2O2/c1-23(21(25)16-18-8-3-2-4-9-18)19-10-12-22(11-7-15-26-22)17-20(19)24-13-5-6-14-24/h2-4,8-9,19-20H,5-7,10-17H2,1H3/t19-,20-,22-/m0/s1 |
PubChem CID | 105104 |
ChEMBL | CHEMBL440765 |
IUPHAR | 1655, 1656 |
BindingDB | 21130 |
DrugBank | N/A |
Structure | ![]() |
Lipinski's druglikeness | This ligand satisfies Lipinski's rule of five. |
Parameter | Value | Reference | Database source |
---|---|---|---|
EC50 | 0.8 nM | PMID25426797 | BindingDB |
EC50 | 0.8 nM | PMID25426797 | ChEMBL |
EC50 | 2.25 nM | PMID17904842 | ChEMBL |
EC50 | 3.2 nM | PMID24121503 | BindingDB |
EC50 | 6.6 nM | PMID16441078 | ChEMBL |
EC50 | 8.03 nM | PMID25248680 | ChEMBL |
EC50 | 11.0 nM | PMID18637671 | ChEMBL |
EC50 | 12.0 nM | PMID25062506, PMID25147605, MedChemComm, (2016) 7:2:317 | BindingDB,ChEMBL |
EC50 | 12.5 nM | PMID22464684 | ChEMBL |
EC50 | 26.1 nM | PMID23134120, PMID12672258 | ChEMBL |
EC50 | 28.0 nM | PMID25283554, PMID26346669 | BindingDB |
EC50 | 28.1 nM | PMID25283554, PMID26346669, PMID23200250 | ChEMBL |
EC50 | 60.14 nM | PMID24657054 | ChEMBL |
EC50 | 64.3 nM | PMID16650985 | ChEMBL |
EC50 | 80.0 nM | PMID24856182, PMID20441176 | ChEMBL |
EC50 | 207.0 nM | PMID17580847, PMID16441078 | ChEMBL |
EC50 | 330.0 nM | PMID17904842 | ChEMBL |
EC50 | 534.0 nM | PMID24613457 | ChEMBL |
ED50 | 24.0 nM | PMID12643930 | ChEMBL |
Emax | 100.0 % | PMID17580847, PMID23134120, PMID16441078, PMID25426797, PMID25147605, PMID17904842, PMID23200250 | ChEMBL |
IC50 | 2.0 nM | PMID12643930, PMID11755353 | BindingDB,ChEMBL |
IC50 | 8.0 nM | PMID20426456 | ChEMBL |
Kd | 1.6 - 2.0 nM | PMID7624359, PMID2986999 | IUPHAR |
Ki | 0.3 nM | PMID23134120, PMID12672258, PMID9686407 | BindingDB,ChEMBL |
Ki | 0.316228 nM | PMID9686407, PMID2986999 | IUPHAR |
Ki | 0.475 nM | PMID20478711 | ChEMBL |
Ki | 0.59 nM | PMID8114680 | BindingDB |
Ki | 1.05 nM | PMID24657054 | ChEMBL |
Ki | 1.11 nM | PMID12930147 | ChEMBL |
Ki | 1.4 nM | PMID10753461 | ChEMBL |
Ki | 1.6 nM | PMID21866885 | ChEMBL |
Ki | 3.5 nM | PMID25599950, PMID23618710, PMID22341895, PMID23880358 | ChEMBL |
Ki | 3.69 nM | PMID15054115 | BindingDB |
Ki | 11.7 nM | PMID15952771 | BindingDB |
Ki | 22.0 nM | PMID24121503 | BindingDB |
Ki | 23.6 nM | PMID15952771 | BindingDB |
Ratio | 15.9 - | PMID16650985 | ChEMBL |
Stimulation | 100.0 % | PMID12672258 | ChEMBL |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417